The findings suggest that the degradation of BPTF induced by 8d hinders the progression of HCC by enhancing the in vivo antitumor activity of NK cells, indicating that a therapeutic strategy targeting BPTF degradation using PROTACs holds promise for halting HCC progression. Here, BPTF is linked to hepatocellular carcinoma.